Gelteq Limited (NASDAQ:GELS) Short Interest Down 32.9% in July

Gelteq Limited (NASDAQ:GELS) saw a large decrease in short interest during the month of July. As of July 15th, there was short interest totaling 112,420 shares, a decrease of 32.9% from the June 30th total of 167,463 shares. Based on an average trading volume of 41,384 shares, the short-interest ratio is presently 2.7 days. Approximately 1.0% of the shares of the stock are sold short.

Gelteq Price Performance

NASDAQ:GELS opened at $0.52 on Friday. The business’s fifty day moving average price is $0.66 and its 200 day moving average price is $0.71. Gelteq has a 1-year low of $0.39 and a 1-year high of $2.02.

Gelteq (NASDAQ:GELS) last issued its earnings results on Tuesday, June 30th. The company reported ($0.12) earnings per share for the quarter.

Institutional Investors Weigh In On Gelteq

An institutional investor recently bought a new stake in Gelteq stock. Susquehanna International Group LLP acquired a new stake in shares of Gelteq Limited (NASDAQ:GELS) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 41,550 shares of the company’s stock, valued at approximately $57,000. Susquehanna International Group LLP owned approximately 0.44% of Gelteq as of its most recent filing with the Securities & Exchange Commission.

Analysts Set New Price Targets

Separately, Weiss Ratings lowered Gelteq from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday, June 26th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of “Sell”.

About Gelteq

Gelteq Inc is a biotechnology company which specializes in the formulation, development and manufacturing of ingestible gel platform designed for nutrient and drug delivery. The Company is focused on advancing and commercializing its delivery solutions within core verticals pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications and sports nutrition. Gelteq Inc is based in NEW YORK.